IRD earnings: a positive outcome, +8.0%

On May 13, 2022, Opus Genetics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.0% in the window around the event. It had already run -32.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.